Drug Profile
Research programme: thrombopoietin variants - Xencor
Alternative Names: Thrombopoietin; TPO variantsLatest Information Update: 02 Oct 2021
Price :
$50
*
At a glance
- Originator Xencor
- Class Antianaemics; Colony-stimulating factors; Glycoproteins; Hepatoprotectants
- Mechanism of Action Thrombopoietin stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Thrombocytopenia
Most Recent Events
- 17 Apr 2006 Discontinued - Preclinical for Thrombocytopenia in USA (unspecified route)
- 22 Aug 2003 Preclinical trials in Thrombocytopenia in USA (unspecified route)